1. Home
  2. JAZZ vs HOMB Comparison

JAZZ vs HOMB Comparison

Compare JAZZ & HOMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAZZ
  • HOMB
  • Stock Information
  • Founded
  • JAZZ 2003
  • HOMB 1998
  • Country
  • JAZZ Ireland
  • HOMB United States
  • Employees
  • JAZZ N/A
  • HOMB N/A
  • Industry
  • JAZZ Biotechnology: Pharmaceutical Preparations
  • HOMB Major Banks
  • Sector
  • JAZZ Health Care
  • HOMB Finance
  • Exchange
  • JAZZ Nasdaq
  • HOMB Nasdaq
  • Market Cap
  • JAZZ 6.1B
  • HOMB 5.0B
  • IPO Year
  • JAZZ 2007
  • HOMB 2006
  • Fundamental
  • Price
  • JAZZ $97.78
  • HOMB $28.58
  • Analyst Decision
  • JAZZ Strong Buy
  • HOMB Hold
  • Analyst Count
  • JAZZ 13
  • HOMB 5
  • Target Price
  • JAZZ $181.85
  • HOMB $31.00
  • AVG Volume (30 Days)
  • JAZZ 1.3M
  • HOMB 915.1K
  • Earning Date
  • JAZZ 05-06-2025
  • HOMB 04-16-2025
  • Dividend Yield
  • JAZZ N/A
  • HOMB 2.79%
  • EPS Growth
  • JAZZ 49.21
  • HOMB 8.29
  • EPS
  • JAZZ 7.51
  • HOMB 2.09
  • Revenue
  • JAZZ $4,064,808,000.00
  • HOMB $987,214,000.00
  • Revenue This Year
  • JAZZ $7.60
  • HOMB $11.25
  • Revenue Next Year
  • JAZZ $3.47
  • HOMB $2.78
  • P/E Ratio
  • JAZZ $13.00
  • HOMB $13.74
  • Revenue Growth
  • JAZZ 5.76
  • HOMB 1.15
  • 52 Week Low
  • JAZZ $95.49
  • HOMB $22.42
  • 52 Week High
  • JAZZ $148.06
  • HOMB $32.91
  • Technical
  • Relative Strength Index (RSI)
  • JAZZ 33.01
  • HOMB 59.90
  • Support Level
  • JAZZ $97.50
  • HOMB $27.96
  • Resistance Level
  • JAZZ $120.67
  • HOMB $28.93
  • Average True Range (ATR)
  • JAZZ 4.33
  • HOMB 0.60
  • MACD
  • JAZZ -0.53
  • HOMB 0.18
  • Stochastic Oscillator
  • JAZZ 1.21
  • HOMB 86.22

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About HOMB Home BancShares Inc.

Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality and a solid balance sheet. The bank's main source of net revenue is net interest income.

Share on Social Networks: